Latest S-1 registration statements

BioLargo, Inc. has filed an S-1 registration statement to allow selling stockholders to resell up to 31,730,651 shares of common stock.

BioLargo, Inc. has filed an S-1 registration statement to allow for the resale of up to 30 million shares of its common stock by selling stockholder Clearthink Capital Partners, LLC.

CitroTech Inc. has filed an amended S-1 registration statement to allow for the resale of up to 8,068,569 shares of its common stock by selling stockholders.

Aptera Motors Corp. has filed a registration statement for the resale of up to 4,751,250 shares of Class B common stock issuable upon the exercise of warrants.

Avalon GloboCare Corp. has filed a registration statement for the resale of up to 19,436,278 shares of its common stock by selling stockholders.

AIAI Holdings Corporation has filed an S-1/A amendment with the SEC, detailing its plan for a direct listing on the Nasdaq Global Market to register the resale of up to 69,483,430 shares of its Class A common stock.

Subversive Bitcoin Acquisition Corp. has filed an amendment to its S-1 registration statement, detailing its initial public offering of units, each consisting of a Class A ordinary share and a redeemable warrant, with a unique strategy involving bitcoin holdings.

Legence Corp. files an S-1MEF to register 2,744,112 additional shares of Class A common stock, supplementing a prior registration.

Energy Transition Special Opportunities, a blank check company, has filed an amendment to its S-1 registration statement for an initial public offering of 15 million units.

Auddia Inc. has filed an amendment to its S-1 registration statement, primarily as an exhibits-only filing, detailing various corporate agreements and governance documents.

Artelo Biosciences, Inc. has filed a Form S-1 registration statement to allow for the resale of up to 9,820,294 shares of common stock by certain selling stockholders.

QumulusAI, Inc. has filed an amended S-1 registration statement with the SEC, detailing its plan for a direct listing on the Nasdaq Global Market.

Grayscale BNB ETF, a Delaware statutory trust, has filed an S-1/A amendment with the SEC to register common units of fractional undivided beneficial interest in the Trust, aiming to list on the Nasdaq Stock Market under the symbol GBNB.

Little West Holdings Inc. has filed an S-1/A amendment detailing its initial public offering of 3,750,000 shares of common stock, with an estimated price range of $4.00 to $6.00 per share.

LB Pharmaceuticals has filed a registration statement for the resale of up to 4,778,491 shares of common stock by existing selling stockholders.

Lakewood-Amedex Biotherapeutics has filed an S-1/A registration statement for a direct listing on the Nasdaq Capital Market.

TEN Holdings, Inc. has filed a registration statement for a proposed public offering of common stock to raise up to $10 million for working capital and debt repayment.

Self-managed healthcare REIT National Healthcare Properties files for a public offering to accelerate its strategic pivot toward senior housing assets.

Legence Corp. filed a registration statement for the secondary offering of 11,000,000 shares of Class A common stock by existing stockholders.

Encore Medical, Inc. has filed an S-1/A amendment to its registration statement, primarily to include Exhibit 4.3, the Form of Investor's Warrant, and an updated Filing Fee Table.

Auddia Inc. has filed an S-1 registration statement detailing an offering of common stock and warrants, with pre-funded warrants available for certain investors.

American Rebel Holdings, Inc. has filed an S-1 registration statement to allow selling stockholders to resell up to 1,196,670 shares of common stock.

Grayscale Bittensor Trust (TAO) has filed an S-1/A amendment with the SEC, detailing its intention to list shares on NYSE Arca under the symbol GTAO, aiming to provide investors with cost-effective exposure to TAO.

Invech Holdings, Inc. has filed a registration statement to register 30,000,000 common shares for resale by GHS Investments LLC under a $10 million equity financing agreement.

Ludwig Enterprises, an early-stage genomics company, is seeking to raise approximately $13.55 million through a firm commitment public offering of common units to fund clinical studies and commercialize its mRNA-based breast cancer test.

Albert Origin Acquisition Corporation, a Cayman Islands blank check company, filed an S-1/A for a $60 million initial public offering of units to pursue a business combination outside of the PRC.

QuasarEdge Acquisition Corporation, a blank check company, filed an amended S-1 registration statement detailing its $100 million IPO, unit structure, and significant risks related to management conflicts and potential China-based acquisitions.

Innovative Digital Investors Acquisition Corp. files S-1/A for a $200M IPO to acquire a financial services business in North America.

Dror Ortho-Design, a pre-revenue medical device company, is pursuing a public offering of up to 3.6 million shares and prefunded warrants to raise $13 million, alongside a 1-for-550 reverse stock split, while facing significant financial challenges and a going concern doubt.

Lakewood-Amedex Biotherapeutics Inc. is pursuing a direct listing on the Nasdaq Capital Market and a $7.5 million Series C Preferred Stock financing to advance its antimicrobial pipeline, despite ongoing significant losses and a going concern warning.